Table 2 Qualitative analysis of overall image quality, artifacts, and lesion conspicuity for both contrast agents and throughout the different perfusion phases.
Extracellular contrast agent (ECA) | Hepatocyte-specific contrast agent (HSCA) | P value | |||
|---|---|---|---|---|---|
Median | IQR | Median | IQR | ||
Image quality | |||||
LAP | 5 | 4–5 | 5 | 4–5 | 1.0 |
PVP | 5 | 4–5 | 4 | 4–5 | 0.041 |
DP | 4 | 4–5 | 4 | 3–5 | 0.008 |
Artifacts | |||||
LAP | 4 | 4–5 | 4 | 3–4 | 0.003 |
PVP | 5 | 4–5 | 4 | 4–5 | 0.034 |
DP | 4 | 4–5 | 4 | 4–5 | 0.078 |
Lesion conspicuity | |||||
LAP | 5 | 4–5 | 4 | 3–4.5 | 0.004 |
PVP | 5 | 4–5 | 5 | 4–5 | 0.037 |
DP | 5 | 4–5 | 5 | 4–5 | 0.073 |
